TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹765 Cr | ₹501 Cr | ₹445 Cr | ₹393 Cr | ₹369 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹765 Cr |
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹393 Cr |
| Mar2022 | ₹369 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹765 Cr | 52.52 | |
| Mar2025 | ₹501 Cr | 12.72 | |
| Mar2024 | ₹445 Cr | 13.14 | |
| Mar2023 | ₹393 Cr | 6.60 | |
| Mar2022 | ₹369 Cr | - | |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹191,151.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| MANKIND PHARMA | ₹99,821.1 Cr | 1.9% | -6.8% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3% |
3% |
34% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses